C22orf31 Inhibitors
Chromosome 22 open reading frame 31 (C22orf31), as denoted by its name, is a protein encoded by an open reading frame located on the 22nd chromosome in humans. Open reading frames (ORFs) are stretches of DNA sequences that have the potential to be translated into proteins. The designation "C22orf31" suggests that this particular ORF is one of many identified on chromosome 22, which is known for its association with several genetic disorders and diseases.
C22orf31 is part of the complex genomic landscape of chromosome 22, which was the first human chromosome to be fully sequenced. Despite this achievement, the specific functions of many ORFs, including C22orf31, often remain elusive until detailed biochemical and functional analyses are conducted. The study of such proteins is essential for understanding the intricate network of genetic interactions that underpin cellular function and human health.Proteins like C22orf31 may play roles in various cellular processes, such as signal transduction, gene regulation, or metabolic pathways. The functional characterization of C22orf31 requires experimental investigations, such as gene expression analysis, protein interaction studies, and phenotypic observations of gene knockouts or overexpression in model organisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, potentially affecting the epigenetic regulation of genes like C22orf31. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, impacting chromatin structure and possibly influencing C22orf31 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine, another DNA methyltransferase inhibitor, can alter gene expression patterns, potentially affecting C22orf31. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor, which could impact the expression of genes including C22orf31. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, may influence chromatin remodeling and gene expression, potentially including C22orf31. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
Olaparib, a PARP inhibitor, affects DNA repair mechanisms, which could indirectly influence C22orf31 if it's involved in DNA repair processes. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen, a selective estrogen receptor modulator, can influence gene expression and might indirectly affect C22orf31. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation, potentially affecting C22orf31 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, can affect protein degradation pathways, potentially influencing C22orf31 if it's involved in these pathways. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Nutlin-3 inhibits MDM2-p53 interaction, potentially influencing gene expression regulation and indirectly affecting C22orf31. | ||||||